Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Obstructive Lung Diseases

  Free Subscription

Articles published in Respir Med

Retrieve available abstracts of 370 articles:
HTML format

Single Articles

    March 2021
  1. YE L, Gao X, Tu C, Du C, et al
    Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China.
    Respir Med. 2021;182:106382.
    PubMed     Abstract available

  2. CHALITSIOS CV, Shaw DE, McKeever TM
    Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis.
    Respir Med. 2021;181:106374.
    PubMed     Abstract available

  3. SAFAVI S, Munidasa S, Zanette B, Dai R, et al
    Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study.
    Respir Med. 2021;180:106368.
    PubMed     Abstract available

  4. LEE JM, Lee SA, Han CH, Lee SM, et al
    Body mass index as a predictor of mortality in bronchiectasis: A nationwide population-based study.
    Respir Med. 2021;180:106370.
    PubMed     Abstract available

  5. KAGOHASHI K, Miyazaki K, Satoh H
    Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics.
    Respir Med. 2021 Mar 6:106358. doi: 10.1016/j.rmed.2021.106358.

  6. MENDY A, Wu X, Keller JL, Fassler CS, et al
    Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients.
    Respir Med. 2021;178:106313.
    PubMed     Abstract available

    February 2021
  7. HAN DW, Jo KW, Kim OH, Shim TS, et al
    Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Respir Med. 2021;179:106340.
    PubMed     Abstract available

  8. UNNI EJ, Gupta S, Sternbach N
    Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence.
    Respir Med. 2021;179:106337.
    PubMed     Abstract available

    January 2021
  9. SCOSYREV E, van Zyl-Smit R, Kerstjens H, Gessner C, et al
    Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
    Respir Med. 2021;180:106311.
    PubMed     Abstract available

  10. SOL IS, Jang H, Noh J, Kim SY, et al
    Mortality and morbidity in children with asthma: A nationwide study in Korea.
    Respir Med. 2021;177:106306.
    PubMed     Abstract available

  11. LIAO SY, Petrache I, Fingerlin TE, Maier LA, et al
    Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
    Respir Med. 2021;176:106275.
    PubMed     Abstract available

  12. CAZZOLA M, Ora J, Bianco A, Rogliani P, et al
    Guidance on nebulization during the current COVID-19 pandemic.
    Respir Med. 2021;176:106236.
    PubMed     Abstract available

    December 2020
  13. CHOATE R, Aksamit TR, Mannino D, Addrizzo-Harris D, et al
    Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.
    Respir Med. 2020;177:106285.
    PubMed     Abstract available

  14. EGER K, Hashimoto S, Braunstahl GJ, Brinke AT, et al
    Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy.
    Respir Med. 2020;177:106287.
    PubMed     Abstract available

  15. SANGIOVANNI S, Morales EI, Fernandez-Trujillo L
    Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
    Respir Med. 2020;176:106283.
    PubMed     Abstract available

  16. LIU Y, Huang X, Chen D, Chen F, et al
    The detrimental qualitative and quantitative alterations of circulating endothelial progenitor cells in patients with bronchiectasis.
    Respir Med. 2020;176:106270.
    PubMed     Abstract available

    November 2020
  17. KUPCZYK M, Majak P, Kuna P, Asankowicz-Bargiel B, et al
    A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical
    Respir Med. 2020;176:106274.
    PubMed     Abstract available

  18. TERVONEN T, Martinez FJ, Hanania NA, Heidenreich S, et al
    Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
    Respir Med. 2020;176:106278.
    PubMed     Abstract available

  19. PULLERITS T, Ronmark EP, Ekerljung L, Palmqvist MA, et al
    The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors.
    Respir Med. 2020;176:106250.
    PubMed     Abstract available

  20. CAMINATI M, Vultaggio A, Matucci A, Senna G, et al
    Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
    Respir Med. 2020;176:106261.
    PubMed     Abstract available

  21. BASSAM M, Behbehani N, Farouk H, Alsayed M, et al
    Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study.
    Respir Med. 2020;176:106244.
    PubMed     Abstract available

  22. GAZOURIAN L, Thedinger WB, Regis SM, Pagura EJ, et al
    Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study.
    Respir Med. 2020;176:106245.
    PubMed     Abstract available

  23. COTTINI M, Licini A, Lombardi C, Berti A, et al
    Prevalence and features of IOS-defined small airway disease across asthma severities.
    Respir Med. 2020;176:106243.
    PubMed     Abstract available

  24. LOMMATZSCH M, Sauerbeck IS, Wilmer C, Taube C, et al
    Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.
    Respir Med. 2020;176:106242.
    PubMed     Abstract available

  25. HUSSEIN MH, Toraih EA, Attia AS, Burley N, et al
    Asthma in COVID-19 patients: An extra chain fitting around the neck?
    Respir Med. 2020;175:106205.
    PubMed     Abstract available

  26. GRAFF S, Bricmont N, Moermans C, Henket M, et al
    Clinical and biological factors associated with irreversible airway obstruction in adult asthma.
    Respir Med. 2020;175:106202.
    PubMed     Abstract available

  27. MOHR A, Plentz A, Sieroslawski A, Pezenburg F, et al
    Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany.
    Respir Med. 2020;174:106207.
    PubMed     Abstract available

  28. FEDDEMA JJ, Claassen E
    Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis.
    Respir Med. 2020;173:106020.
    PubMed     Abstract available

  29. RAISANEN P, Hedman L, Andersson M, Stridsman C, et al
    Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population.
    Respir Med. 2020;173:106017.
    PubMed     Abstract available

    October 2020
  30. QIN L, Li Z, Fan Y, Fang X, et al
    Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function.
    Respir Med. 2020;175:106208.
    PubMed     Abstract available

  31. PAOLETTI G, Keber E, Heffler E, Malipiero G, et al
    Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma.
    Respir Med. 2020;174:106199.
    PubMed     Abstract available

  32. GESSNER C, Kornmann O, Maspero J, van Zyl-Smit R, et al
    Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority stu
    Respir Med. 2020 Oct 17:106186. doi: 10.1016/j.rmed.2020.106186.

  33. LITT HK, Press VG, Hull A, Siros M, et al
    Association between inhaler technique and confidence among hospitalized children with asthma.
    Respir Med. 2020;174:106191.
    PubMed     Abstract available

  34. MORILLO-VANEGAS D, Sanchez-Salcedo P, Sebastian Arino AF
    Relationship between pediatric asthma and psychosocial status of caregivers.
    Respir Med. 2020;174:106187.
    PubMed     Abstract available

    September 2020
  35. LASSMANN-KLEE PG, Piirila PL, Brumpton B, Larsson M, et al
    Parallel gradients in FENO and in the prevalences of asthma and atopy in adult general populations of Sweden, Finland and Estonia - A Nordic EpiLung study.
    Respir Med. 2020;173:106160.
    PubMed     Abstract available

  36. BUSBY J, Khoo E, Pfeffer PE, Mansur AH, et al
    The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.
    Respir Med. 2020;173:106156.
    PubMed     Abstract available

  37. FOSTER JM, Beasley R, Braithwaite I, Harrison T, et al
    Patient experiences of as-needed budesonide-formoterol by Turbuhaler(R) for treatment of mild asthma; a qualitative study.
    Respir Med. 2020;175:106154.
    PubMed     Abstract available

  38. BAGNASCO D, Brussino L, Bonavia M, Calzolari E, et al
    Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
    Respir Med. 2020;171:106080.
    PubMed     Abstract available

  39. FITZGERALD JM, Arnetorp S, Smare C, Gibson D, et al
    The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    Respir Med. 2020;171:106079.
    PubMed     Abstract available

  40. CHAN KPF, Ma TF, Kwok WC, Leung JKC, et al
    Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic.
    Respir Med. 2020;171:106085.
    PubMed     Abstract available

    Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis.
    Respir Med. 2020;171:106096.
    PubMed     Abstract available

    August 2020
  42. WU TJ, Chen CH, Chen BY, Chin WS, et al
    Ambient air pollution and asthma onset in Taiwanese adults.
    Respir Med. 2020;172:106133.
    PubMed     Abstract available

  43. MARTINEZ-GARCIA MA, Posadas T, Sotgiu G, Blasi F, et al
    Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials.
    Respir Med. 2020;172:106127.

  44. KAHNERT K, Jorres RA, Kauczor HU, Biederer J, et al
    Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET.
    Respir Med. 2020;172:106117.
    PubMed     Abstract available

  45. LIANG Y, Wang D, Hua D, Liao H, et al
    Short-term oral corticosteroids for initial treatment of moderate-to-severe persistent asthma: A double-blind, randomized, placebo-controlled trial.
    Respir Med. 2020;172:106126.
    PubMed     Abstract available

  46. DE NIJS SB, Krop EJM, Portengen L, Rijssenbeek-Nouwens LH, et al
    Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma.
    Respir Med. 2020;171:106123.
    PubMed     Abstract available

  47. IELPO A, Crisafulli E, Alcaraz-Serrano V, Gabarrus A, et al
    Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.
    Respir Med. 2020;172:106090.
    PubMed     Abstract available

  48. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2020 Aug 5:106106. doi: 10.1016/j.rmed.2020.106106.

  49. PEEL AM, Wilkinson M, Sinha A, Loke YK, et al
    Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review.
    Respir Med. 2020;169:105984.
    PubMed     Abstract available

  50. SPRIO AE, Ciprandi G, Riccardi E, Giannoccaro F, et al
    The influence of smoking on asthma in the real-life.
    Respir Med. 2020;170:106066.
    PubMed     Abstract available

  51. MUKHOPADHYAY A, Waked M, Gogtay J, Gaur V, et al
    Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Respir Med. 2020;170:106055.
    PubMed     Abstract available

  52. HASAN SS, Capstick T, Zaidi STR, Kow CS, et al
    Use of corticosteroids in asthma and COPD patients with or without COVID-19.
    Respir Med. 2020;170:106045.
    PubMed     Abstract available

  53. OH JH, Ahn KM, Chung SJ, Shim JS, et al
    Usefulness of routine blood test-driven clusters for predicting acute exacerbation in patients with asthma.
    Respir Med. 2020;170:106042.
    PubMed     Abstract available

  54. BASLER L, Saxer S, Schneider SR, Lichtblau M, et al
    Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: Randomized parallel-group trial.
    Respir Med. 2020;170:106040.
    PubMed     Abstract available

  55. TSE SM
    Asthma-related hospitalizations following critical asthma in children: A comparison between Canada and the United States.
    Respir Med. 2020;170:106028.
    PubMed     Abstract available

  56. FOY BH, Natarajan S, Munawar A, Soares M, et al
    Characterising the role of small airways in severe asthma using low frequency forced oscillations: A combined computational and clinical approach.
    Respir Med. 2020;170:106022.
    PubMed     Abstract available

  57. GESSNER C, Kornmann O, Maspero J, van Zyl-Smit R, et al
    Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON).
    Respir Med. 2020;170:106021.
    PubMed     Abstract available

  58. CRIMI C, Campisi R, Noto A, Genco S, et al
    Comparability of asthma control test scores between self and physician-administered test.
    Respir Med. 2020;170:106015.
    PubMed     Abstract available

  59. MEERBURG JJ, Veerman GDM, Aliberti S, Tiddens HAWM, et al
    Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: A systematic review.
    Respir Med. 2020;170:105954.
    PubMed     Abstract available

  60. OUAALAYA EH, Falque L, Dupis JM, Sabatini M, et al
    Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?
    Respir Med. 2020;169:106018.
    PubMed     Abstract available

  61. ARO M, Saaresranta T, Vahlberg T, Anttalainen U, et al
    Medication of comorbidities in females with sleep-disordered breathing during long-term CPAP therapy.
    Respir Med. 2020;169:106014.
    PubMed     Abstract available

    July 2020
  62. NG CACM, Knuiman MW, Murray K, Divitini ML, et al
    Childhood asthma increases respiratory morbidity, but not all-cause mortality in adulthood: The Busselton Health Study.
    Respir Med. 2020;171:106095.
    PubMed     Abstract available

  63. GARCIA-PACHON E, Zamora-Molina L, Soler-Sempere MJ, Baeza-Martinez C, et al
    Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.
    Respir Med. 2020;171:106084.
    PubMed     Abstract available

  64. POTT J, Krill A, Wilkens H, Bals R, et al
    Easy measurement of health related quality of life in patients with cystic fibrosis by the COPD assessment test (CAT) - A pilot study.
    Respir Med. 2020;168:105992.
    PubMed     Abstract available

  65. SHANKAR PS, Korukonda K, Bendre S, Behera D, et al
    Diagnoses and management of adult cough: An Indian Environmental Medical Association (EMA) position paper.
    Respir Med. 2020;168:105949.
    PubMed     Abstract available

    June 2020
  66. LIPPI G, Henry BM
    Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).
    Respir Med. 2020;167:105941.

  67. LEWIS A, Nolan CM, Man WDC, Kon SSC, et al
    Prognostication in COPD using physical function measures: Let's walk before we run away with conclusions.
    Respir Med. 2020;167:105942.

  68. JONES TPW, Brown J, Hurst JR, Vancheeswaran R, et al
    COPD exacerbation phenotypes in a real-world five year hospitalisation cohort.
    Respir Med. 2020;167:105979.
    PubMed     Abstract available

    May 2020
  69. ZAMARRON E, Romero D, Fernandez-Lahera J, Villasante C, et al
    Should we consider paranasal and chest computed tomography in severe asthma patients?
    Respir Med. 2020;169:106013.
    PubMed     Abstract available

  70. SHIRAI T, Furuuchi K, Fujiwara K, Nakamoto K, et al
    Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
    Respir Med. 2020;166:105955.
    PubMed     Abstract available

  71. LARSSON-CALLERFELT AK, Muller C, Andersson-Sjoland A, Thiman L, et al
    VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Respir Med. 2020;166:105944.
    PubMed     Abstract available

  72. BEZERRA DE MENEZES M, Ponte EV, Bertagni Mingotti CF, Carvalho Pinto RM, et al
    Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal nationwide study.
    Respir Med. 2020;166:105950.
    PubMed     Abstract available

  73. VOGELMEIER CF, Roman-Rodriguez M, Singh D, Han MK, et al
    Goals of COPD treatment: Focus on symptoms and exacerbations.
    Respir Med. 2020;166:105938.
    PubMed     Abstract available

    April 2020
  74. CANONICA GW, Malvezzi L, Blasi F, Paggiaro P, et al
    Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Respir Med. 2020;166:105947.
    PubMed     Abstract available

  75. BOUTOU AK, Daniil Z, Pitsiou G, Papakosta D, et al
    Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?
    Respir Med. 2020;167:105953.
    PubMed     Abstract available

  76. KOLTERMANN V, Friedrich FO, Fensterseifer AC, Ongaratto R, et al
    Cost-benefit impact of free asthma medication provision for the pediatric population.
    Respir Med. 2020;164:105915.
    PubMed     Abstract available

  77. DIAZ-GARCIA R, Flores-Ramirez G, Ramirez-Oseguera RT
    Effect of extrafine formulation of BDP/FF inhaler on asthma control, small airway function and airway inflammation among Mexican asthmatic patients. A retrospective analysis.
    Respir Med. 2020;165:105932.
    PubMed     Abstract available

  78. MULGIRIGAMA A, Barnes N, Fletcher M, Pedersen S, et al
    Corrigendum to "A review of the burden and management of mild asthma in adults - Implications for clinical practice" [Respir. Med. 152 (2019) 97-104].
    Respir Med. 2020;165:105872.

  79. FASTENAU A, van Schayck OC, Winkens B, Aretz K, et al
    Effectiveness of an exercise training programme COPD in primary care: A randomized controlled trial.
    Respir Med. 2020;165:105943.
    PubMed     Abstract available

    March 2020
  80. IMAM JS, Duarte AG
    Non-CF bronchiectasis: Orphan disease no longer.
    Respir Med. 2020;166:105940.
    PubMed     Abstract available

  81. VETRANO DL, Zucchelli A, Bianchini E, Marconi E, et al
    Patterns of oral corticosteroids use in primary care patients with severe asthma.
    Respir Med. 2020;166:105946.
    PubMed     Abstract available

  82. LAVORINI F, Bianco A, Blasi F, Braido F, et al
    What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis.
    Respir Med. 2020;166:105937.
    PubMed     Abstract available

  83. SCHNEEBERGER T, Jarosch I, Moll J, Gloeckl R, et al
    Increased asthma control after a 3-week inpatient pulmonary rehabilitation program.
    Respir Med. 2020;165:105930.

  84. ENGELKES M, de Ridder MA, Svensson E, Berencsi K, et al
    Multinational cohort study of mortality in patients with asthma and severe asthma.
    Respir Med. 2020;165:105919.
    PubMed     Abstract available

  85. RODRIGUEZ-AGUILAR M, Diaz de Leon-Martinez L, Gorocica-Rosete P, Padilla RP, et al
    Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose.
    Respir Med. 2020;163:105901.
    PubMed     Abstract available

    February 2020
  86. CAZZOLA M, Matera MG
    The effect of doxofylline in asthma and COPD.
    Respir Med. 2020;164:105904.
    PubMed     Abstract available

  87. DE KEYSER HEH, Kaye L, Anderson WC, Gondalia R, et al
    Electronic medication monitors help determine adherence subgroups in asthma.
    Respir Med. 2020;164:105914.
    PubMed     Abstract available

  88. SEDEH FB, Von Bulow A, Backer V, Bodtger U, et al
    The impact of dysfunctional breathing on the level of asthma control in difficult asthma.
    Respir Med. 2020;163:105894.
    PubMed     Abstract available

  89. LANARIO JW, Hyland ME, Wei Y, Jones RC, et al
    Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma.
    Respir Med. 2020;162:105870.
    PubMed     Abstract available

  90. MARC-MALOVRH M, Camlek L, Skrgat S, Kern I, et al
    Elevated eosinophils, IL5 and IL8 in induced sputum in asthma patients with accelerated FEV1 decline.
    Respir Med. 2020;162:105875.
    PubMed     Abstract available

  91. MINGOTTI C, Sarinho J, Stanigher K, Silva J, et al
    Evaluating the FEV1/FVC ratio in the lower range of normality as a marker of worse clinical outcomes in asthmatic subjects without airway obstruction.
    Respir Med. 2020;162:105880.
    PubMed     Abstract available

  92. JANSSON SA, Backman H, Andersson M, Telg G, et al
    Severe asthma is related to high societal costs and decreased health related quality of life.
    Respir Med. 2020;162:105860.
    PubMed     Abstract available

  93. WAN ES, Kantorowski A, Polak M, Kadri R, et al
    Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations.
    Respir Med. 2020;162:105878.
    PubMed     Abstract available

  94. ZHOU M, Tan KS, Guan WJ, Jiang LJ, et al
    Proteomics profiling of epithelium-derived exosomes from nasal polyps revealed signaling functions affecting cellular proliferation.
    Respir Med. 2020;162:105871.
    PubMed     Abstract available

    January 2020
  95. KIM C, Ko Y, Jung JY, Lee JS, et al
    Severe vitamin D deficiency is associated with emphysema progression in male patients with COPD.
    Respir Med. 2020;163:105890.
    PubMed     Abstract available

  96. MILGER K, Korn S, Buhl R, Hamelmann E, et al
    Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort.
    Respir Med. 2020;162:105858.
    PubMed     Abstract available

  97. KORNMANN O, Mucsi J, Kolosa N, Bandelli L, et al
    Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings.
    Respir Med. 2020;161:105809.
    PubMed     Abstract available

  98. MASSIERER D, Alsowayan W, Lima VP, Bourbeau J, et al
    Prognostic value of simple measures of physical function and muscle strength in COPD: A systematic review.
    Respir Med. 2020;161:105856.
    PubMed     Abstract available

  99. MEYS R, Sillen MJ, Franssen FME, Stoffels AAF, et al
    Impact of mild-to-moderate exacerbations on outcomes of neuromuscular electrical stimulation (NMES) in patients with COPD.
    Respir Med. 2020;161:105851.
    PubMed     Abstract available

  100. MAHLER DA
    The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease.
    Respir Med. 2020;161:105857.
    PubMed     Abstract available

  101. BALAMURUGAN S, Apte K, Singh BP, Deb AK, et al
    Device-handling study of a novel breath-actuated inhaler, Synchrobreathe(R), versus a pMDI.
    Respir Med. 2020;161:105707.
    PubMed     Abstract available

  102. MASARWEH K, Gur M, Leiba R, Bar-Yoseph R, et al
    Factors predicting length of stay in bronchiolitis.
    Respir Med. 2020;161:105824.
    PubMed     Abstract available

  103. PROULX F, Laberge S, Macovoz N, Tse SM, et al
    Predictive factors for a shortened methacholine challenge protocol in children.
    Respir Med. 2020;161:105823.
    PubMed     Abstract available

    December 2019
  104. BUHL R, Heaney LG, Loefroth E, Larbig M, et al
    One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings.
    Respir Med. 2019;162:105859.
    PubMed     Abstract available

    November 2019
  105. CRUZ AA, Riley JH, Bansal AT, Ponte EV, et al
    Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status.
    Respir Med. 2019;161:105817.
    PubMed     Abstract available

  106. MATUCCI A, Maggi E, Vultaggio A
    Eosinophils, the IL-5/IL-5Ralpha axis, and the biologic effects of benralizumab in severe asthma.
    Respir Med. 2019;160:105819.
    PubMed     Abstract available

  107. FRANCONERI A, Marasco E, Dore R, Codullo V, et al
    Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis.
    Respir Med. 2019;160:105816.
    PubMed     Abstract available

  108. DE JONG CC, Mozun R
    The reference standard in diagnostic studies on childhood asthma.
    Respir Med. 2019 Nov 6:105812. doi: 10.1016/j.rmed.2019.105812.

  109. MANON-JENSEN T, Langholm LL, Ronnow SR, Karsdal MA, et al
    End-product of fibrinogen is elevated in emphysematous chronic obstructive pulmonary disease and is predictive of mortality in the ECLIPSE cohort.
    Respir Med. 2019;160:105814.
    PubMed     Abstract available

  110. ALBERS FC, Licskai C, Chanez P, Bratton DJ, et al
    Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.
    Respir Med. 2019;159:105806.
    PubMed     Abstract available

  111. ZACCAGNINI M, Esquinas AM, Karim HMR
    In response to Galindo-Filho et al. A mesh nebulizer is more effective than jet nebulizer during noninvasive ventilation of COPD subjects: A few practical points.
    Respir Med. 2019;160:105754.

  112. BOUTOU AK, Papathanassiou M, Chloros A
    Bone mineral density and associated fractures in COPD patients: The role of inflammation and pulmonary rehabilitation.
    Respir Med. 2019;160:105708.

    October 2019
  113. CAMPO P, Soto Campos G, Aparicio MB, Jorge AM, et al
    Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.
    Respir Med. 2019;159:105804.
    PubMed     Abstract available

  114. LABABIDI HM, AlSowayigh OM, BinHowemel SF, AlReshaid KM, et al
    Refractory asthma phenotyping based on immunoglobulin E levels and eosinophilic counts: A real life study.
    Respir Med. 2019;158:55-58.
    PubMed     Abstract available

  115. TEMAM S, Chanoine S, Bedard A, Dumas O, et al
    Low socioeconomic position and neighborhood deprivation are associated with uncontrolled asthma in elderly.
    Respir Med. 2019;158:70-77.
    PubMed     Abstract available

    September 2019
  116. CASALE TB, Aalbers R, Bleecker ER, Meltzer EO, et al
    Tiotropium Respimat(R) add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics.
    Respir Med. 2019;158:97-109.
    PubMed     Abstract available

  117. SNELL N, Gibson J, Jarrold I, Quint JK, et al
    Epidemiology of bronchiectasis in the UK: Findings from the British lung foundation's 'Respiratory health of the nation' project.
    Respir Med. 2019;158:21-23.
    PubMed     Abstract available

  118. LIU BC, Huang TX, Yang D, Yang L, et al
    Asthma-associated bronchiectasis: More attention needed!
    Respir Med. 2019 Sep 12. pii: S0954-6111(19)30289.

    August 2019
  119. TAY TR, Choo XN, Yii A, Chung KF, et al
    Asthma phenotypes in a multi-ethnic Asian cohort.
    Respir Med. 2019;157:42-48.
    PubMed     Abstract available

  120. GROSBOIS JM, Coquart J, Fry S, Le Rouzic O, et al
    Long-term effect of home-based pulmonary rehabilitation in severe asthma.
    Respir Med. 2019;157:36-41.
    PubMed     Abstract available

  121. KESSLER A, Kragl U, Glass A, Schmidt S, et al
    Exhaled nitric oxide can't replace the methacholine challenge in suspected pediatric asthma.
    Respir Med. 2019;157:21-25.
    PubMed     Abstract available

  122. OKONKWO CS, Davis BE, Blais CM, Cockcroft DW, et al
    Short-term effect of once-daily fluticasone furoate on methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2019;156:53-57.
    PubMed     Abstract available

  123. CAZZOLA M, Rogliani P, Matera MG
    Ultra-LABAs for the treatment of asthma.
    Respir Med. 2019;156:47-52.
    PubMed     Abstract available

    July 2019
  124. ELSHEIKH MS, Mohamed NH, Alsharkawy AAA
    Improvement of asthma control after laser acupuncture and its impact on exhaled 8-isoprostane as an oxidative biomarker in chronic bronchial asthma.
    Respir Med. 2019;156:15-19.
    PubMed     Abstract available

  125. HISINGER-MOLKANEN H, Pallasaho P, Haahtela T, Lindqvist A, et al
    The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland.
    Respir Med. 2019;155:121-126.
    PubMed     Abstract available

  126. MOORE LE, Kapoor K, Byers BW, Brotto AR, et al
    Acute effects of salbutamol on systemic vascular function in people with asthma.
    Respir Med. 2019;155:133-140.
    PubMed     Abstract available

  127. FELDMAN LY, Zhu J, To T
    Estimating age-specific influenza-associated asthma morbidity in Ontario, Canada.
    Respir Med. 2019;155:104-112.
    PubMed     Abstract available

  128. ALVES AM, Marques de Mello L, Lima Matos AS, Cruz AA, et al
    Severe asthma: Comparison of different classifications of severity and control.
    Respir Med. 2019;156:1-7.
    PubMed     Abstract available

  129. VISSER SK, Bye PTP, Fox GJ, Burr LD, et al
    Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry.
    Respir Med. 2019;155:97-103.
    PubMed     Abstract available

  130. KUO CR, Spears M, Haughney J, Smith A, et al
    Scottish consensus statement on the role of FeNO in adult asthma.
    Respir Med. 2019;155:54-57.
    PubMed     Abstract available

  131. GRAHAM LM, Kerstjens HAM, Vogelberg C, Hamelmann E, et al
    Safety of tiotropium Respimat((R)) in black or African-American patients with symptomatic asthma.
    Respir Med. 2019;155:58-60.
    PubMed     Abstract available

    June 2019
  132. GROSSO A, Pesce G, Marcon A, Piloni D, et al
    Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study.
    Respir Med. 2019;155:6-12.
    PubMed     Abstract available

  133. DIMITROVA D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, et al
    Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma.
    Respir Med. 2019;154:144-154.
    PubMed     Abstract available

  134. CORDOVA-RIVERA L, Gibson PG, Gardiner PA, Hiles SA, et al
    Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.
    Respir Med. 2019;154:93-101.
    PubMed     Abstract available

  135. MANSFIELD L, Bernstein JA
    Tiotropium in asthma: From bench to bedside.
    Respir Med. 2019;154:47-55.
    PubMed     Abstract available

  136. OCAL S, Portakal O, Ocal A, Demir AU, et al
    Corrigendum to "Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects" [Respir. Med. (2016) 119109-114].
    Respir Med. 2019 Jun 11. pii: S0954-6111(19)30165.

  137. ALCARAZ-SERRANO V, Fernandez-Barat L, Scioscia G, Llorens-Llacuna J, et al
    Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis.
    Respir Med. 2019;154:40-46.
    PubMed     Abstract available

  138. HUMBERT M, Albers FC, Bratton DJ, Yancey SW, et al
    Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.
    Respir Med. 2019;154:69-75.
    PubMed     Abstract available

  139. HONKAMAKI J, Hisinger-Molkanen H, Ilmarinen P, Piirila P, et al
    Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood.
    Respir Med. 2019;154:56-62.
    PubMed     Abstract available

  140. MULGIRIGAMA A, Barnes N, Fletcher M, Pedersen S, et al
    A review of the burden and management of mild asthma in adults - Implications for clinical practice.
    Respir Med. 2019;152:97-104.
    PubMed     Abstract available

  141. GRAFF S, Demarche S, Henket M, Paulus V, et al
    Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma.
    Respir Med. 2019;152:60-66.
    PubMed     Abstract available

  142. MANISCALCO M, Calabrese C, D'Amato M, Guida P, et al
    Association between exhaled nitric oxide and nasal polyposis in severe asthma.
    Respir Med. 2019;152:20-24.
    PubMed     Abstract available

  143. MANTYLA J, Mazur W, Torola T, Bergman P, et al
    Asthma as aetiology of bronchiectasis in Finland.
    Respir Med. 2019;152:105-111.
    PubMed     Abstract available

  144. TYRAK KE, Kuprys-Lipinska I, Czarnobilska E, Jakiela B, et al
    Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Respir Med. 2019;152:51-59.
    PubMed     Abstract available

    May 2019
  145. MONTALBANO L, Ferrante G, Cilluffo G, Gentile M, et al
    Targeting quality of life in asthmatic children: The MyTEP pilot randomized trial.
    Respir Med. 2019;153:14-19.
    PubMed     Abstract available

  146. MATERA MG, Calzetta L, Rogliani P, Cazzola M, et al
    Monoclonal antibodies for severe asthma: Pharmacokinetic profiles.
    Respir Med. 2019;153:3-13.
    PubMed     Abstract available

  147. KOSKELA HO, Latti AM, Pekkanen J
    Subfreezing air as a cough trigger and multiple triggers are strongly associated with the presence of asthma in chronic cough.
    Respir Med. 2019;153:26-30.
    PubMed     Abstract available

  148. BAI C, Jiang D, Wang L, Xue F, et al
    A high blood eosinophil count may be a risk factor for incident asthma in population at risk.
    Respir Med. 2019;151:59-65.
    PubMed     Abstract available

  149. PEREZ DE LLANO L, Martinez-Moragon E, Plaza Moral V, Trisan Alonso A, et al
    Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
    Respir Med. 2019;151:49-54.

  150. CAZZOLA M, Rogliani P, Calzetta L, Matera MG, et al
    Bronchodilators in subjects with asthma-related comorbidities.
    Respir Med. 2019;151:43-48.
    PubMed     Abstract available

  151. KERWIN EM, Hickey L, Small CJ
    Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone.
    Respir Med. 2019;151:35-42.
    PubMed     Abstract available

  152. YANCEY SW, Bradford ES, Keene ON
    Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of >/=150-300cells/muL.
    Respir Med. 2019;151:139-141.
    PubMed     Abstract available

  153. DIEL R, Ewig S, Blaas S, Jacob C, et al
    Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
    Respir Med. 2019;151:121-127.
    PubMed     Abstract available

  154. LICARI A, Brambilla I, Sacchi L, Marseglia G, et al
    Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children.
    Respir Med. 2019;151:118-120.
    PubMed     Abstract available

  155. DOMVRI K, Porpodis K, Tzimagiorgis G, Chatzopoulou F, et al
    Th2/Th17 cytokine profile in phenotyped Greek asthmatics and relationship to biomarkers of inflammation.
    Respir Med. 2019;151:102-110.
    PubMed     Abstract available

  156. MOON SM, Jhun BW, Baek SY, Kim S, et al
    Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Respir Med. 2019;151:1-7.
    PubMed     Abstract available

  157. ERIKSSON G, Nolte H, Ljorring C, Riis B, et al
    Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial.
    Respir Med. 2019;153:1-2.

    April 2019
  158. WANG M, Liu M, Wang C, Xiao Y, et al
    Association between vitamin D status and asthma control: A meta-analysis of randomized trials.
    Respir Med. 2019;150:85-94.
    PubMed     Abstract available

  159. LEE E, Shim JY, Kim HY, Suh DI, et al
    Clinical characteristics and etiologies of bronchiectasis in Korean children: A multicenter retrospective study.
    Respir Med. 2019;150:8-14.
    PubMed     Abstract available

  160. SEGURA-MEDINA P, Vargas MH, Aguilar-Romero JM, Arreola-Ramirez JL, et al
    Mold burden in house dust and its relationship with asthma control.
    Respir Med. 2019;150:74-80.
    PubMed     Abstract available

  161. TARIQ K, Schofield JPR, Nicholas BL, Burg D, et al
    Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma.
    Respir Med. 2019;150:66-73.
    PubMed     Abstract available

  162. KATSAOUNOU P, Buhl R, Brusselle G, Pfister P, et al
    Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Respir Med. 2019;150:51-62.
    PubMed     Abstract available

  163. KWON BS, Lee JH, Koh Y, Kim WS, et al
    The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Respir Med. 2019;150:45-50.
    PubMed     Abstract available

  164. KWON JW, Jung H, Kim SH, Chang YS, et al
    High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function.
    Respir Med. 2019;150:38-44.
    PubMed     Abstract available

  165. ICHIKAWA T, Panariti A, Audusseau S, Mogas AK, et al
    Effect of bronchial thermoplasty on structural changes and inflammatory mediators in the airways of subjects with severe asthma.
    Respir Med. 2019;150:165-172.
    PubMed     Abstract available

  166. AARAB R, Vijverberg SJH, Prins M, Snijder MB, et al
    Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study.
    Respir Med. 2019;150:113-119.
    PubMed     Abstract available

  167. AWERBACH JD, Stackhouse KA, Lee J, Dahhan T, et al
    Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
    Respir Med. 2019;150:126-130.
    PubMed     Abstract available

    March 2019
  168. YANG D, Huang T, Liu B, Liu C, et al
    To the editor: Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?
    Respir Med. 2019 Mar 16. pii: S0954-6111(19)30079.

  169. FARAH CS, Badal T, Reed N, Rogers PG, et al
    Mepolizumab improves small airway function in severe eosinophilic asthma.
    Respir Med. 2019;148:49-53.
    PubMed     Abstract available

  170. SASSO F, Izard M, Beneteau T, Rakotozandry T, et al
    18-year evolution of asthma and allergic diseases in French urban schoolchildren in relation to indoor air pollutant levels.
    Respir Med. 2019;148:31-36.
    PubMed     Abstract available

  171. FERRI S, Crimi C, Heffler E, Campisi R, et al
    Vitamin D and disease severity in bronchiectasis.
    Respir Med. 2019;148:1-5.
    PubMed     Abstract available

  172. KURUVILLA ME, Vanijcharoenkarn K, Shih JA, Lee FE, et al
    Epidemiology and risk factors for asthma.
    Respir Med. 2019;149:16-22.

  173. ALVES JUNIOR SF, Zanetti G, Alves de Melo AS, Souza AS Jr, et al
    Neurofibromatosis type 1: State-of-the-art review with emphasis on pulmonary involvement.
    Respir Med. 2019;149:9-15.
    PubMed     Abstract available

  174. MOY ML, Harrington KF, Sternberg AL, Krishnan JA, et al
    Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.
    Respir Med. 2019;149:52-58.
    PubMed     Abstract available

  175. STOLK J, Aggarwal N, Hochnadel I, Wrenger S, et al
    Blood monocyte profiles in COPD patients with PiMM and PiZZ alpha1-antitrypsin.
    Respir Med. 2019;148:60-62.
    PubMed     Abstract available

  176. CEN J, Ma H, Chen Z, Weng L, et al
    Monitoring peak expiratory flow could predict COPD exacerbations: A prospective observational study.
    Respir Med. 2019;148:43-48.
    PubMed     Abstract available

  177. KAMEYAMA N, Chubachi S, Sasaki M, Tsutsumi A, et al
    Predictive and modifying factors of bone mineral density decline in patients with COPD.
    Respir Med. 2019;148:13-23.
    PubMed     Abstract available

    February 2019
  178. KOSSE RC, Bouvy ML, de Vries TW, Koster ES, et al
    Effect of a mHealth intervention on adherence in adolescents with asthma: A randomized controlled trial.
    Respir Med. 2019 Feb 16. pii: S0954-6111(19)30045.
    PubMed     Abstract available

  179. JEMINIWA R, Hohmann L, Qian J, Garza K, et al
    Impact of eHealth on medication adherence among patients with asthma: A systematic review and meta-analysis.
    Respir Med. 2019 Feb 15. pii: S0954-6111(19)30047.
    PubMed     Abstract available

  180. TAPONEN S, Uitti J, Karvala K, Luukkonen R, et al
    Asthma diagnosed in late adulthood is linked to work disability and poor employment status.
    Respir Med. 2019;147:76-78.
    PubMed     Abstract available

  181. CIOLKOWSKI J, Emeryk A, Hydzik P, Emeryk-Maksymiuk J, et al
    Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
    Respir Med. 2019;147:7-12.
    PubMed     Abstract available

  182. BJERMER L, Eriksson G, Radner F, Peterson S, et al
    Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma.
    Respir Med. 2019;147:19-25.
    PubMed     Abstract available

  183. BAKERLY ND, Woodcock A, Collier S, Leather DA, et al
    Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups.
    Respir Med. 2019;147:58-65.
    PubMed     Abstract available

  184. PAPI A, Zheng J, Criner GJ, Fabbri LM, et al
    Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study.
    Respir Med. 2019;147:37-43.
    PubMed     Abstract available

  185. FORMIGA MF, Vital I, Urdaneta G, Campos MA, et al
    Beyond inspiratory muscle strength: Clinical utility of single-breath work capacity assessment in veterans with COPD.
    Respir Med. 2019;147:13-18.
    PubMed     Abstract available

  186. KELLER K, Hobohm L, Munzel T, Ostad MA, et al
    Impact of chronic obstructive pulmonary disease on the outcomes of patients with peripheral artery disease.
    Respir Med. 2019;147:1-6.
    PubMed     Abstract available

    January 2019
  187. KATSOULIS K, Ismailos G, Kipourou M, Kostikas K, et al
    Microbiota and asthma: Clinical implications.
    Respir Med. 2019;146:28-35.

  188. ALSUMRAIN M, De Giacomi F, Nasim F, Koo CW, et al
    Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival.
    Respir Med. 2019;146:106-112.
    PubMed     Abstract available

  189. BALDACCI S, Simoni M, Maio S, Angino A, et al
    Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice.
    Respir Med. 2019;146:10-17.
    PubMed     Abstract available

  190. CONDE DIEZ S, Viejo Casas A, Garcia Rivero JL, Lopez Caro JC, et al
    Impact of a homeopathic medication on upper respiratory tract infections in COPD patients: Results of an observational, prospective study (EPOXILO).
    Respir Med. 2019;146:96-105.
    PubMed     Abstract available

  191. REIJNDERS T, Schuler M, Wittmann M, Jelusic D, et al
    The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD.
    Respir Med. 2019;146:87-95.
    PubMed     Abstract available

  192. YASUI H, Inui N, Karayama M, Mori K, et al
    Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
    Respir Med. 2019;146:76-80.
    PubMed     Abstract available

  193. CHARBONNIER JP, Pompe E, Moore C, Humphries S, et al
    Airway wall thickening on CT: Relation to smoking status and severity of COPD.
    Respir Med. 2019;146:36-41.
    PubMed     Abstract available

  194. HILL K, Ng C, Wootton SL, McKeough ZJ, et al
    The minimal detectable difference for endurance shuttle walk test performance in people with COPD on completion of a program of high-intensity ground-based walking.
    Respir Med. 2019;146:18-22.
    PubMed     Abstract available

  195. KYOMOTO Y, Kanazawa H, Tochino Y, Watanabe T, et al
    Possible role of airway microvascular permeability on airway obstruction in patients with chronic obstructive pulmonary disease.
    Respir Med. 2019;146:137-141.
    PubMed     Abstract available

  196. CARSIN AE, Fuertes E, Schaffner E, Jarvis D, et al
    Restrictive spirometry pattern is associated with low physical activity levels. A population based international study.
    Respir Med. 2019;146:116-123.
    PubMed     Abstract available

  197. PAINE NJ, Bacon SL, Bourbeau J, Tan WC, et al
    Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study.
    Respir Med. 2019;146:1-9.
    PubMed     Abstract available

    December 2018
  198. LIMA-MATOS A, Ponte EV, de Jesus JPV, Almeida PCA, et al
    Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians.
    Respir Med. 2018;145:95-100.
    PubMed     Abstract available

  199. MATTHES S, Stadler J, Barton J, Leuschner G, et al
    Asthma features in severe COPD: Identifying treatable traits.
    Respir Med. 2018;145:89-94.
    PubMed     Abstract available

  200. ZENG J, Chen Z, Hu Y, Hu Q, et al
    Asthma control in preschool children with small airway function as measured by IOS and fractional exhaled nitric oxide.
    Respir Med. 2018;145:8-13.
    PubMed     Abstract available

  201. BALTIERI L, Cazzo E, de Souza AL, Alegre SM, et al
    Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up.
    Respir Med. 2018;145:48-56.
    PubMed     Abstract available

  202. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.
    Respir Med. 2018;145:41-47.
    PubMed     Abstract available

  203. HOSSEINI SA, Zilaee M, Shoushtari MH, Ghasemi Dehcheshmeh M, et al
    An evaluation of the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with mild and moderate persistent allergic asthma: A triple-blind, randomized placebo-controlled trial.
    Respir Med. 2018;145:28-34.
    PubMed     Abstract available

  204. PEREIRA AA, Pollard SL, Locke R, Romero K, et al
    Association between exhaled carbon monoxide and asthma outcomes in Peruvian children.
    Respir Med. 2018;145:212-216.
    PubMed     Abstract available

  205. AJALA O, Zhang Y, Gupta A, Bon J, et al
    Decreased serum TRAIL is associated with increased mortality in smokers with comorbid emphysema and coronary artery disease.
    Respir Med. 2018;145:21-27.
    PubMed     Abstract available

  206. O'NEILL K, Lakshmipathy GR, Ferguson K, Cosgrove D, et al
    Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study.
    Respir Med. 2018;145:206-211.
    PubMed     Abstract available

  207. RADOVANOVIC D, Santus P, Blasi F, Sotgiu G, et al
    A comprehensive approach to lung function in bronchiectasis.
    Respir Med. 2018;145:120-129.
    PubMed     Abstract available

  208. MAO S, Wu L, Shi W
    Association between trace elements levels and asthma susceptibility.
    Respir Med. 2018;145:110-119.
    PubMed     Abstract available

    November 2018
  209. NGUYEN TS, Nguyen TLH, Pham TTV, Cao TBT, et al
    Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling - A simulated patient study.
    Respir Med. 2018;144:50-60.
    PubMed     Abstract available

  210. NORDON C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, et al
    Clinical and economic burden of severe asthma: A French cohort study.
    Respir Med. 2018;144:42-49.
    PubMed     Abstract available

  211. JEPPEGAARD M, Veidal S, Sverrild A, Backer V, et al
    Validation of ATS clinical practice guideline cut-points for FeNO in asthma.
    Respir Med. 2018;144:22-29.
    PubMed     Abstract available

    October 2018
  212. BUHL R, FitzGerald JM, Busse WW
    Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta2-agonists for adults with asthma.
    Respir Med. 2018;143:82-90.
    PubMed     Abstract available

  213. MANSUR AH, Srivastava S, Sahal A
    Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Respir Med. 2018;143:31-38.
    PubMed     Abstract available

  214. DAVIES SE, Bishopp A, Wharton S, Turner AM, et al
    Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review.
    Respir Med. 2018;143:18-30.
    PubMed     Abstract available

  215. SCHUERMANS D, Hanon S, Wauters I, Verbanck S, et al
    Impact of a single 10 min education session on asthma control as measured by ACT.
    Respir Med. 2018;143:14-17.
    PubMed     Abstract available

  216. XIN L, Gao J, Ge X, Tian C, et al
    Increased pro-inflammatory cytokine-secreting regulatory T cells are correlated with the plasticity of T helper cell differentiation and reflect disease status in asthma.
    Respir Med. 2018;143:129-138.
    PubMed     Abstract available

  217. BIANCHI L, Bezzi M, Berlendis M, Marino S, et al
    Additive effect on pulmonary function and disability of intensive pulmonary rehabilitation following bronchoscopy lung volume reduction (BLVR) for severe emphysema.
    Respir Med. 2018;143:116-122.
    PubMed     Abstract available

  218. ALMOMANI BA, Mokhemer E, Al-Sawalha NA, Momany SM, et al
    A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma.
    Respir Med. 2018;143:103-108.
    PubMed     Abstract available

    September 2018
  219. MUNESWARAO J, Hassali MA, Verma AK
    Comment on "A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma".
    Respir Med. 2018 Sep 19. pii: S0954-6111(18)30294.

  220. BERTI A, Volcheck GW, Cornec D, Smyth RJ, et al
    Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;142:66-72.
    PubMed     Abstract available

  221. HEFFLER E, Crimi C, Mancuso S, Campisi R, et al
    Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.
    Respir Med. 2018;142:48-52.
    PubMed     Abstract available

  222. CAVALLAZZI R, Jorayeva A, Beatty BL, Antimisiaris D, et al
    Predicting asthma in older adults on the basis of clinical history.
    Respir Med. 2018;142:36-40.
    PubMed     Abstract available

  223. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    30-year trends in asthma and the trends in relation to hospitalization and mortality.
    Respir Med. 2018;142:29-35.
    PubMed     Abstract available

  224. PAPAIOANNOU AI, Diamant Z, Bakakos P, Loukides S, et al
    Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.
    Respir Med. 2018;142:15-22.
    PubMed     Abstract available

  225. DE BENEDETTO F, Pastorelli R, Ferrario M, de Blasio F, et al
    Supplementation with Qter((R)) and Creatine improves functional performance in COPD patients on long term oxygen therapy.
    Respir Med. 2018;142:86-93.
    PubMed     Abstract available

  226. SORIANO JB, Hahsler M, Soriano C, Martinez C, et al
    Temporal transitions in COPD severity stages within the GOLD 2017 classification system.
    Respir Med. 2018;142:81-85.
    PubMed     Abstract available

  227. BOGART M, Stanford RH, Reinsch T, Hull M, et al
    Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study.
    Respir Med. 2018;142:73-80.
    PubMed     Abstract available

  228. VAES AW, Spruit MA, Theunis J, Wouters EFM, et al
    Peripheral endothelial function is positively associated with maximal aerobic capacity in patients with chronic obstructive pulmonary disease.
    Respir Med. 2018;142:41-47.
    PubMed     Abstract available

    August 2018
  229. PODDIGHE D, Brambilla I, Licari A, Marseglia GL, et al
    Pediatric rhinosinusitis and asthma.
    Respir Med. 2018;141:94-99.
    PubMed     Abstract available

  230. COUMOU H, Westerhof GA, de Nijs SB, Amelink M, et al
    Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level.
    Respir Med. 2018;141:81-86.
    PubMed     Abstract available

  231. BAZAN-SOCHA S, Kuczia P, Potaczek DP, Mastalerz L, et al
    Increased blood levels of cellular fibronectin in asthma: Relation to the asthma severity, inflammation, and prothrombotic blood alterations.
    Respir Med. 2018;141:64-71.
    PubMed     Abstract available

  232. ADACHI M, Kozawa M, Yoshisue H, Lee Milligan K, et al
    Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
    Respir Med. 2018;141:56-63.
    PubMed     Abstract available

  233. SVEDSATER H, Jones R, Bosanquet N, Jacques L, et al
    Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.
    Respir Med. 2018;141:198-206.
    PubMed     Abstract available

  234. LYCETT H, Wildman E, Raebel EM, Sherlock JP, et al
    Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence.
    Respir Med. 2018;141:180-189.
    PubMed     Abstract available

  235. MCDONNELL MJ, O'Toole D, Ward C, Pearson JP, et al
    A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.
    Respir Med. 2018;141:132-143.
    PubMed     Abstract available

  236. DEVILLIER P, Humbert M, Boye A, Zachgo W, et al
    Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting beta2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial.
    Respir Med. 2018;141:111-120.
    PubMed     Abstract available

  237. SCHULER M, Wittmann M, Faller H, Schultz K, et al
    Including changes in dyspnea after inpatient rehabilitation improves prediction models of exacerbations in COPD.
    Respir Med. 2018;141:87-93.
    PubMed     Abstract available

  238. KOUIJZER M, Brusse-Keizer M, Bode C
    COPD-related fatigue: Impact on daily life and treatment opportunities from the patient's perspective.
    Respir Med. 2018;141:47-51.
    PubMed     Abstract available

  239. OHAR JA, Loh CH, Lenoir KM, Wells BJ, et al
    A comprehensive care plan that reduces readmissions after acute exacerbations of COPD.
    Respir Med. 2018;141:20-25.
    PubMed     Abstract available

  240. DOMENECH A, Munoz-Montiel A, Garcia-Casares N, Rioja J, et al
    High risk of subclinical atherosclerosis in COPD exacerbator phenotype.
    Respir Med. 2018;141:165-171.
    PubMed     Abstract available

  241. KAWAMOTO T, Kanazawa H, Tochino Y, Kawaguchi T, et al
    Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
    Respir Med. 2018;141:159-164.
    PubMed     Abstract available

  242. FANER R, Noell G, Badia JR, Lopez-Giraldo A, et al
    Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.
    Respir Med. 2018;141:14-19.
    PubMed     Abstract available

  243. GOOD JT JR, Rollins DR, Kolakowski CA, Stevens AD, et al
    New insights in the diagnosis of chronic refractory cough.
    Respir Med. 2018;141:103-110.
    PubMed     Abstract available

  244. SCHISSLER AJ, Celli BR
    Prevalence of paradoxical bronchoconstriction after inhaled albuterol.
    Respir Med. 2018;141:100-102.
    PubMed     Abstract available

  245. SIEVI NA, Brack T, Brutsche MH, Frey M, et al
    Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years.
    Respir Med. 2018;141:1-6.
    PubMed     Abstract available

    July 2018
  246. CHEN A, Nowrouzi-Kia B, Usuba K
    Health-related quality of life in Canadians with asthma: A case-control study using census data.
    Respir Med. 2018;140:82-86.
    PubMed     Abstract available

  247. CHUNG WS, Lin CL
    Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study.
    Respir Med. 2018;140:6-10.
    PubMed     Abstract available

  248. POULSEN NN, Bjerregaard A, Khoo SK, Laing IA, et al
    Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.
    Respir Med. 2018;140:50-56.
    PubMed     Abstract available

  249. ZHANG HP, Wang L, Wang Z, Xu XR, et al
    Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial.
    Respir Med. 2018;140:42-49.
    PubMed     Abstract available

  250. LABAKI WW, Xia M, Murray S, Curtis JL, et al
    NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Respir Med. 2018;140:87-93.
    PubMed     Abstract available

  251. WAN ES, Kantorowski A, Homsy D, Kadri R, et al
    Self-reported task-oriented physical activity: A comparison with objective daily step count in COPD.
    Respir Med. 2018;140:63-70.
    PubMed     Abstract available

  252. HENRIKSEN DP, Davidsen JR, Laursen CB
    Nationwide use of theophylline among adults-A 20-year Danish drug utilisation study.
    Respir Med. 2018;140:57-62.
    PubMed     Abstract available

  253. JUNG IY, Jeong SJ, Lee KM, Ahn JY, et al
    Risk factors for mortality in patients with Pseudomonas aeruginosa pneumonia: Clinical impact of mucA gene mutation.
    Respir Med. 2018;140:27-31.
    PubMed     Abstract available

  254. BEHROOZ L, Balekian DS, Faridi MK, Espinola JA, et al
    Prenatal and postnatal tobacco smoke exposure and risk of severe bronchiolitis during infancy.
    Respir Med. 2018;140:21-26.
    PubMed     Abstract available

  255. SIAFAKAS N, Bizymi N, Mathioudakis A, Corlateanu A, et al
    EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD).
    Respir Med. 2018;140:127-131.
    PubMed     Abstract available

  256. HYLDGAARD C, Bendstrup E, Pedersen AB, Ulrichsen SP, et al
    Increased mortality among patients with rheumatoid arthritis and COPD: A population-based study.
    Respir Med. 2018;140:101-107.
    PubMed     Abstract available

    June 2018
  257. DE ROOS EW, Lahousse L, Verhamme KMC, Braunstahl GJ, et al
    Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.
    Respir Med. 2018;139:6-12.
    PubMed     Abstract available

  258. MUNGAN D, Aydin O, Mahboub B, Albader M, et al
    Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program.
    Respir Med. 2018;139:55-64.
    PubMed     Abstract available

  259. KERWIN E, Wachtel A, Sher L, Nyberg J, et al
    Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
    Respir Med. 2018;139:39-47.
    PubMed     Abstract available

  260. KARVALA K, Uitti J, Taponen S, Luukkonen R, et al
    Asthma trigger perceptions are associated with work disability.
    Respir Med. 2018;139:19-26.
    PubMed     Abstract available

  261. NAKAMOTO K, Saraya T, Ogawa Y, Ishii H, et al
    Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;139:101-105.
    PubMed     Abstract available

  262. HAHN B, Hull M, Blauer-Peterson C, Buikema AR, et al
    Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA.
    Respir Med. 2018;139:65-71.
    PubMed     Abstract available

  263. FERRARI R, Caram LMO, Tanni SE, Godoy I, et al
    The relationship between Vitamin D status and exacerbation in COPD patients- a literature review.
    Respir Med. 2018;139:34-38.
    PubMed     Abstract available

  264. LIU S, Zhou Y, Liu S, Zou W, et al
    Clinical impact of the lower limit of normal of FEV1/FVC on detecting chronic obstructive pulmonary disease: A follow-up study based on cross-sectional data.
    Respir Med. 2018;139:27-33.
    PubMed     Abstract available

  265. GOVE K, Wilkinson T, Jack S, Ostridge K, et al
    Systematic review of evidence for relationships between physiological and CT indices of small airways and clinical outcomes in COPD.
    Respir Med. 2018;139:117-125.
    PubMed     Abstract available

  266. DESVEAUX L, Harrison SL, Gagnon JF, Goldstein RS, et al
    Effects of exercise training on cognition in chronic obstructive pulmonary disease: A systematic review.
    Respir Med. 2018;139:110-116.
    PubMed     Abstract available

  267. LIPWORTH BJ, Jabbal S
    What can we learn about COPD from impulse oscillometry?
    Respir Med. 2018;139:106-109.
    PubMed     Abstract available

    May 2018
  268. JACOB J, Odink A, Brun AL, Macaluso C, et al
    Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.
    Respir Med. 2018;138:95-101.
    PubMed     Abstract available

  269. ZAFARI Z, Sadatsafavi M, Chen W, FitzGerald JM, et al
    The projected economic and health burden of sub-optimal asthma control in Canada.
    Respir Med. 2018;138:7-12.
    PubMed     Abstract available

  270. TARRAF H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, et al
    Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.
    Respir Med. 2018;138:64-73.
    PubMed     Abstract available

  271. OLUWOLE O, Rennie DC, Senthilselvan A, Dyck R, et al
    The association between endotoxin and beta-(1-->3)-D-glucan in house dust with asthma severity among schoolchildren.
    Respir Med. 2018;138:38-46.
    PubMed     Abstract available

  272. BACKMAN H, Jansson SA, Stridsman C, Muellerova H, et al
    Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.
    Respir Med. 2018;138:115-122.
    PubMed     Abstract available

  273. KAPPELER D, Sommerer K, Kietzig C, Huber B, et al
    Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
    Respir Med. 2018;138:107-114.
    PubMed     Abstract available

  274. MCNAMARA RJ, Houben-Wilke S, Franssen FME, Smid DE, et al
    Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease.
    Respir Med. 2018;138:81-87.
    PubMed     Abstract available

  275. FAKIH F, Spangenthal S, Sigal B, Darken P, et al
    Randomized study of the effects of Aerochamber Plus((R)) Flow-Vu((R)) on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Respir Med. 2018;138:74-80.
    PubMed     Abstract available

  276. OLIVEIRA A, Rodrigues J, Marques A
    Enhancing our understanding of computerised adventitious respiratory sounds in different COPD phases and healthy people.
    Respir Med. 2018;138:57-63.
    PubMed     Abstract available

  277. BHATTA L, Leivseth L, Mai XM, Chen Y, et al
    Prevalence and trend of COPD from 1995-1997 to 2006-2008: The HUNT study, Norway.
    Respir Med. 2018;138:50-56.
    PubMed     Abstract available

  278. BRUSSELLE G, Pavord ID, Landis S, Pascoe S, et al
    Blood eosinophil levels as a biomarker in COPD.
    Respir Med. 2018;138:21-31.
    PubMed     Abstract available

  279. MORALES DR, Flynn R, Zhang J, Trucco E, et al
    External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.
    Respir Med. 2018;138:150-155.
    PubMed     Abstract available

  280. NADERI N, Assayag D, Mostafavi-Pour-Manshadi SM, Kaddaha Z, et al
    Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
    Respir Med. 2018;138:129-136.
    PubMed     Abstract available

  281. CORDOBA-LANUS E, Cabrera-Lopez C, Cazorla-Rivero S, Rodriguez-Perez MC, et al
    Shorter telomeres in non-smoking patients with airflow limitation.
    Respir Med. 2018;138:123-128.
    PubMed     Abstract available

    April 2018
  282. VAHATALO I, Ilmarinen P, Tuomisto LE, Niemela O, et al
    Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Respir Med. 2018;137:70-76.
    PubMed     Abstract available

  283. LIN J, Wang W, Chen P, Zhou X, et al
    Prevalence and risk factors of asthma in mainland China: The CARE study.
    Respir Med. 2018;137:48-54.
    PubMed     Abstract available

  284. SATIRER O, Mete Yesil A, Emiralioglu N, Tugcu GD, et al
    A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.
    Respir Med. 2018;137:35-39.
    PubMed     Abstract available

  285. THOMSEN AML, Ehrenstein V, Riis AH, Toft G, et al
    The potential impact of paternal age on risk of asthma in childhood: a study within the Danish National Birth Cohort.
    Respir Med. 2018;137:30-34.
    PubMed     Abstract available

  286. QU Y, Zhang C, Hu Z, Li S, et al
    The 100 most influential publications in asthma from 1960 to 2017: A bibliometric analysis.
    Respir Med. 2018;137:206-212.
    PubMed     Abstract available

  287. DY T, Lewis EM, Murugan V, Gehlert S, et al
    Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
    Respir Med. 2018;137:201-205.
    PubMed     Abstract available

  288. WACHTEL H, Nagel M, Engel M, El Azzi G, et al
    In vitro and clinical characterization of the valved holding chamber AeroChamber Plus((R)) Flow-Vu((R)) for administrating tiotropium Respimat((R)) in 1-5-year-old children with persistent asthmatic symptoms.
    Respir Med. 2018;137:181-190.
    PubMed     Abstract available

  289. KURT OK, Ergun D, Basaran N
    Can the ceramic industry be a new and hazardous sector for work-related asthma?
    Respir Med. 2018;137:176-180.
    PubMed     Abstract available

  290. VAN HIRTUM PV, Sprooten RTM, van Noord JA, van Vliet M, et al
    Long term survival after admission for COPD exacerbation: A comparison with the general population.
    Respir Med. 2018;137:77-82.
    PubMed     Abstract available

  291. VAZ FRAGOSO CA, Van Ness PH, Murphy TE, McAvay GJ, et al
    Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.
    Respir Med. 2018;137:40-47.
    PubMed     Abstract available

  292. LANGTON D, Wang W, Thien F, Plummer V, et al
    The acute effects of bronchial thermoplasty on FEV1.
    Respir Med. 2018;137:147-151.
    PubMed     Abstract available

  293. ALTER P, Watz H, Kahnert K, Pfeifer M, et al
    Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling.
    Respir Med. 2018;137:14-22.
    PubMed     Abstract available

  294. CHEROT-KORNOBIS N, Hulo S, Giovannelli J, de Broucker V, et al
    Exhaled breath NOx levels in a middle-aged adults population-based study: reference values and association with the smoking status.
    Respir Med. 2018;137:134-140.
    PubMed     Abstract available

  295. CHEN YW, Coxson HO, Coupal TM, Lam S, et al
    The contribution of thoracic vertebral deformity and arthropathy to trunk pain in patients with chronic obstructive pulmonary disease (COPD).
    Respir Med. 2018;137:115-122.
    PubMed     Abstract available

  296. MILNER SC, Boruff JT, Beaurepaire C, Ahmed S, et al
    Rate of, and barriers and enablers to, pulmonary rehabilitation referral in COPD: A systematic scoping review.
    Respir Med. 2018;137:103-114.
    PubMed     Abstract available

  297. REITER J, Breuer A, Breuer O, Hashavya S, et al
    A quality improvement intervention to reduce emergency department radiography for bronchiolitis.
    Respir Med. 2018;137:1-5.
    PubMed     Abstract available

    March 2018
  298. BRUMPTON BM, Langhammer A, Henriksen AH, Romundstad PR, et al
    Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study.
    Respir Med. 2018;136:65-70.
    PubMed     Abstract available

  299. CIPRANDI G, Schiavetti I, Ricciardolo FLM
    The impact of aging on outpatients with asthma in a real-world setting.
    Respir Med. 2018;136:58-64.
    PubMed     Abstract available

  300. ZELT JT, Jones JH, Hirai DM, King TJ, et al
    Systemic vascular dysfunction is associated with emphysema burden in mild COPD.
    Respir Med. 2018;136:29-36.
    PubMed     Abstract available

  301. LISSPERS K, Janson C, Larsson K, Johansson G, et al
    Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).
    Respir Med. 2018;136:15-20.
    PubMed     Abstract available

  302. SUAREZ-CUARTIN G, Giner J, Merino JL, Rodrigo-Troyano A, et al
    Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.
    Respir Med. 2018;136:111-117.
    PubMed     Abstract available

  303. KRIDIN K, Comaneshter D, Batat E, Cohen AD, et al
    COPD and lung cancer in patients with pemphigus- a population based study.
    Respir Med. 2018;136:93-97.
    PubMed     Abstract available

  304. MIRAVITLLES M, Sliwinski P, Rhee CK, Costello RW, et al
    Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.
    Respir Med. 2018;136:8-14.
    PubMed     Abstract available

  305. EPSTEIN D, Nasser R, Mashiach T, Azzam ZS, et al
    Increased red cell distribution width: A novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease.
    Respir Med. 2018;136:1-7.
    PubMed     Abstract available

    February 2018
  306. GOULD CF, Perzanowski MS, Evans D, Bruzzese JM, et al
    Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.
    Respir Med. 2018;135:42-50.
    PubMed     Abstract available

  307. MARTINEZ-RIVERA C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, et al
    Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Respir Med. 2018;135:22-28.
    PubMed     Abstract available

  308. VARGAS MH, Becerril-Angeles M, Medina-Reyes IS, Rascon-Pacheco RA, et al
    Altitude above 1500m is a major determinant of asthma incidence. An ecological study.
    Respir Med. 2018;135:1-7.
    PubMed     Abstract available

  309. RODRIGUEZ-JIMENEZ JC, Moreno-Paz FJ, Teran LM, Guani-Guerra E, et al
    Aspirin exacerbated respiratory disease: Current topics and trends.
    Respir Med. 2018;135:62-75.
    PubMed     Abstract available

  310. SIKJAER MG, Lokke A, Hilberg O
    The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.
    Respir Med. 2018;135:35-41.
    PubMed     Abstract available

    Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices.
    Respir Med. 2018;135:12-14.
    PubMed     Abstract available

    January 2018
  312. SUZUKAWA M, Matsumoto H, Ohshima N, Tashimo H, et al
    Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
    Respir Med. 2018;134:95-102.
    PubMed     Abstract available

  313. KORENBLAT P, Kerwin E, Leshchenko I, Yen K, et al
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
    Respir Med. 2018;134:143-149.
    PubMed     Abstract available

  314. HAUGHNEY J, Morice A, Blyth KG, Lee AJ, et al
    A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Respir Med. 2018;134:117-123.
    PubMed     Abstract available

  315. GAO YH, Liu SX, Cui JJ, Wang LY, et al
    Subclinical atherosclerosis in adults with steady-state bronchiectasis: A case-control study.
    Respir Med. 2018;134:110-116.
    PubMed     Abstract available

  316. KAHNERT K, Alter P, Young D, Lucke T, et al
    The revised GOLD 2017 COPD categorization in relation to comorbidities.
    Respir Med. 2018;134:79-85.
    PubMed     Abstract available

  317. MIRAVITLLES M, Menezes A, Lopez Varela MV, Casas A, et al
    Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Respir Med. 2018;134:62-69.
    PubMed     Abstract available

  318. FERGUSON GT, Hickey AJ, Dwivedi S
    Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
    Respir Med. 2018;134:16-23.
    PubMed     Abstract available

  319. DE BLASIO F, Di Gregorio A, de Blasio F, Bianco A, et al
    Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables.
    Respir Med. 2018;134:1-5.
    PubMed     Abstract available

    December 2017
  320. VILMANN L, Buchvald F, Green K, Nielsen KG, et al
    Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children.
    Respir Med. 2017;133:42-47.
    PubMed     Abstract available

  321. NICHOLSON A, Pollard SL, Lima JJ, Romero KM, et al
    Serum folate concentrations, asthma, atopy, and asthma control in Peruvian children.
    Respir Med. 2017;133:29-35.
    PubMed     Abstract available

  322. LAWSON JA, Brozek G, Shpakou A, Fedortsiv O, et al
    An international comparison of asthma, wheeze, and breathing medication use among children.
    Respir Med. 2017;133:22-28.
    PubMed     Abstract available

  323. SZENTPETERY SS, Gruzieva O, Forno E, Han YY, et al
    Combined effects of multiple risk factors on asthma in school-aged children.
    Respir Med. 2017;133:16-21.
    PubMed     Abstract available

    November 2017
  324. JUDSON MA
    Endpoints in sarcoidosis: More like IPF or asthma?
    Respir Med. 2017 Nov 20. pii: S0954-6111(17)30384.

  325. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    PubMed     Abstract available

  326. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    PubMed     Abstract available

  327. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    PubMed     Abstract available

  328. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    PubMed     Abstract available

  329. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    PubMed     Abstract available

  330. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.

  331. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    PubMed     Abstract available

    October 2017
  332. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    PubMed     Abstract available

  333. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    PubMed     Abstract available

  334. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    PubMed     Abstract available

  335. AGGELOU K, Siafakas N
    Medical lung volume reduction for severe emphysema: A review.
    Respir Med. 2017;131:141-147.
    PubMed     Abstract available

  336. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    PubMed     Abstract available

  337. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Abstract available

    September 2017
  338. TALINI D, Ciberti A, Bartoli D, Del Guerra P, et al
    Work-related asthma in a sample of subjects with established asthma.
    Respir Med. 2017;130:85-91.
    PubMed     Abstract available

  339. MANISCALCO M, Zamparelli AS, Vitale DF, Faraone S, et al
    Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
    Respir Med. 2017;130:69-74.
    PubMed     Abstract available

  340. DI BONA D, Fiorino I, Taurino M, Frisenda F, et al
    Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
    Respir Med. 2017;130:55-60.
    PubMed     Abstract available

  341. COX CA, Boudewijn IM, Vroegop SJ, Schokker S, et al
    Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Med. 2017;130:35-42.
    PubMed     Abstract available

  342. TANNO LK, Haahtela T, Calderon MA, Cruz A, et al
    Implementation gaps for asthma prevention and control.
    Respir Med. 2017;130:13-19.
    PubMed     Abstract available

    June 2017
  343. DI MARCO F, Terraneo S, Job S, Rinaldo RF, et al
    Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry.
    Respir Med. 2017;127:7-13.
    PubMed     Abstract available

  344. LIN J, Li J, Yu W, Liu Y, et al
    A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Respir Med. 2017;127:45-50.
    PubMed     Abstract available

  345. MACEDO P, Zhang Q, Saito J, Liang Z, et al
    Analysis of bronchial biopsies in chronic cough.
    Respir Med. 2017;127:40-44.
    PubMed     Abstract available

  346. KONNO S, Makita H, Suzuki M, Shimizu K, et al
    Acute bronchodilator responses to beta2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
    Respir Med. 2017;127:14-20.
    PubMed     Abstract available

    May 2017
  347. GLOECKL R, Jarosch I, Bengsch U, Claus M, et al
    What's the secret behind the benefits of whole-body vibration training in patients with COPD? A randomized, controlled trial.
    Respir Med. 2017;126:17-24.
    PubMed     Abstract available

  348. MESQUITA R, Meijer K, Pitta F, Azcuna H, et al
    Changes in physical activity and sedentary behaviour following pulmonary rehabilitation in patients with COPD.
    Respir Med. 2017;126:122-129.
    PubMed     Abstract available

  349. HANANIA NA, Tashkin DP, Kerwin EM, Donohue JF, et al
    Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension Delivery Technology in patients with chronic obstructive pulmonary disease.
    Respir Med. 2017;126:105-115.
    PubMed     Abstract available

    April 2017
  350. HAYES D JR, Tumin D, Budev MM, Tobias JD, et al
    Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
    Respir Med. 2017 Apr 22. pii: S0954-6111(17)30127.
    PubMed     Abstract available

  351. BODINI R, Santus P, Di Marco F, Aliberti S, et al
    Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy.
    Respir Med. 2017;125:8-11.
    PubMed     Abstract available

  352. DI MARCO F, Santus P, Scichilone N, Solidoro P, et al
    Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Respir Med. 2017;125:49-56.
    PubMed     Abstract available

  353. D'URZO A, Rennard S, Kerwin E, Donohue JF, et al
    A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.
    Respir Med. 2017;125:39-48.
    PubMed     Abstract available

  354. SHIH YN, Chen YT, Chu H, Shih CJ, et al
    Association of pre-hospital theophylline use and mortality in chronic obstructive pulmonary disease patients with sepsis.
    Respir Med. 2017;125:33-38.
    PubMed     Abstract available

  355. TOTTENBORG SS, Lange P, Thomsen RW, Nielsen H, et al
    Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative.
    Respir Med. 2017;125:19-23.
    PubMed     Abstract available

  356. HONG JY, Jung JY, Lee MG, Kim SK, et al
    Changes in the prevalence of COPD in Korea between 2001 and 2011 in the KNHANES data.
    Respir Med. 2017;125:12-18.
    PubMed     Abstract available

    March 2017
  357. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    PubMed     Abstract available

  358. KARDOS P, Vogelmeier C, Worth H, Buhl R, et al
    A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
    Respir Med. 2017;124:57-64.
    PubMed     Abstract available

    February 2017
  359. BOURBEAU J, Aaron SD, Barnes NC, Davis KJ, et al
    Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.
    Respir Med. 2017;123:94-97.
    PubMed     Abstract available

  360. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    Chronic bronchitis in relation to hospitalization and mortality over three decades.
    Respir Med. 2017;123:87-93.
    PubMed     Abstract available

  361. SILER TM, Nagai A, Scott-Wilson CA, Midwinter DA, et al
    A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 mug versus once-daily vilanterol 25 mug to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD.
    Respir Med. 2017;123:8-17.
    PubMed     Abstract available

  362. OYAMA Y, Enomoto N, Suzuki Y, Kono M, et al
    Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE).
    Respir Med. 2017;123:63-70.
    PubMed     Abstract available

  363. POMPE E, Galban CJ, Ross BD, Koenderman L, et al
    Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease.
    Respir Med. 2017;123:48-55.
    PubMed     Abstract available

  364. WANG LY, Zhu YN, Cui JJ, Yin KQ, et al
    Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2017;123:18-27.
    PubMed     Abstract available

  365. MELZER AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, et al
    Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD.
    Respir Med. 2017;123:124-130.
    PubMed     Abstract available

  366. DELLWEG D, Reissig K, Hoehn E, Siemon K, et al
    Inspiratory muscle training during rehabilitation in successfully weaned hypercapnic patients with COPD.
    Respir Med. 2017;123:116-123.
    PubMed     Abstract available

    January 2017
  367. BUHL R, Magder S, Bothner U, Tetzlaff K, et al
    Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Respir Med. 2017;122:58-66.
    PubMed     Abstract available

  368. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    PubMed     Abstract available

  369. PAULIN FV, Zagatto AM, Chiappa GR, Muller PT, et al
    Addition of vitamin B12 to exercise training improves cycle ergometer endurance in advanced COPD patients: A randomized and controlled study.
    Respir Med. 2017;122:23-29.
    PubMed     Abstract available

  370. MUELLER S, Wilke T, Bechtel B, Punekar YS, et al
    Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Respir Med. 2017;122:1-11.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.